Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Receptor Tyrosine Protein Kinase ERBB 3 Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 BA-0702
      • 1.3.3 CDX-3379
      • 1.3.4 Elgemtumab
      • 1.3.5 ETBX-031
      • 1.3.6 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Application (2019-2025)
      • 1.4.2 Non-Small Cell Carcinoma
      • 1.4.3 Solid Tumor
      • 1.4.4 Melanoma
      • 1.4.5 Colorectal Cancer
      • 1.4.6 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size
      • 2.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue 2014-2025
      • 2.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales 2014-2025
    • 2.2 Receptor Tyrosine Protein Kinase ERBB 3 Growth Rate by Regions
      • 2.2.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Regions 2014-2019
      • 2.2.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Receptor Tyrosine Protein Kinase ERBB 3 Sales by Manufacturers
      • 3.1.1 Receptor Tyrosine Protein Kinase ERBB 3 Sales by Manufacturers 2014-2019
      • 3.1.2 Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Manufacturers (2014-2019)
      • 3.2.2 Receptor Tyrosine Protein Kinase ERBB 3 Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Concentration Ratio (CR5 and HHI)
    • 3.3 Receptor Tyrosine Protein Kinase ERBB 3 Price by Manufacturers
    • 3.4 Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Receptor Tyrosine Protein Kinase ERBB 3 Market
    • 3.6 Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 BA-0702 Sales and Revenue (2014-2019)
      • 4.1.2 CDX-3379 Sales and Revenue (2014-2019)
      • 4.1.3 Elgemtumab Sales and Revenue (2014-2019)
      • 4.1.4 ETBX-031 Sales and Revenue (2014-2019)
      • 4.1.5 Others Sales and Revenue (2014-2019)
    • 4.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Type
    • 4.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Type
    • 4.4 Receptor Tyrosine Protein Kinase ERBB 3 Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Application

    6 United States

    • 6.1 United States Receptor Tyrosine Protein Kinase ERBB 3 Breakdown Data by Company
    • 6.2 United States Receptor Tyrosine Protein Kinase ERBB 3 Breakdown Data by Type
    • 6.3 United States Receptor Tyrosine Protein Kinase ERBB 3 Breakdown Data by Application

    7 European Union

    • 7.1 European Union Receptor Tyrosine Protein Kinase ERBB 3 Breakdown Data by Company
    • 7.2 European Union Receptor Tyrosine Protein Kinase ERBB 3 Breakdown Data by Type
    • 7.3 European Union Receptor Tyrosine Protein Kinase ERBB 3 Breakdown Data by Application

    8 China

    • 8.1 China Receptor Tyrosine Protein Kinase ERBB 3 Breakdown Data by Company
    • 8.2 China Receptor Tyrosine Protein Kinase ERBB 3 Breakdown Data by Type
    • 8.3 China Receptor Tyrosine Protein Kinase ERBB 3 Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Receptor Tyrosine Protein Kinase ERBB 3 Breakdown Data by Company
    • 9.2 Rest of World Receptor Tyrosine Protein Kinase ERBB 3 Breakdown Data by Type
    • 9.3 Rest of World Receptor Tyrosine Protein Kinase ERBB 3 Breakdown Data by Application
    • 9.4 Rest of World Receptor Tyrosine Protein Kinase ERBB 3 Breakdown Data by Countries
      • 9.4.1 Rest of World Receptor Tyrosine Protein Kinase ERBB 3 Sales by Countries
      • 9.4.2 Rest of World Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 AstraZeneca Plc
      • 10.1.1 AstraZeneca Plc Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 3
      • 10.1.4 Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction
      • 10.1.5 AstraZeneca Plc Recent Development
    • 10.2 AVEO Pharmaceuticals, Inc.
      • 10.2.1 AVEO Pharmaceuticals, Inc. Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 3
      • 10.2.4 Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction
      • 10.2.5 AVEO Pharmaceuticals, Inc. Recent Development
    • 10.3 Etubics Corporation
      • 10.3.1 Etubics Corporation Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 3
      • 10.3.4 Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction
      • 10.3.5 Etubics Corporation Recent Development
    • 10.4 F. Hoffmann-La Roche Ltd.
      • 10.4.1 F. Hoffmann-La Roche Ltd. Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 3
      • 10.4.4 Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction
      • 10.4.5 F. Hoffmann-La Roche Ltd. Recent Development
    • 10.5 GamaMabs Pharma S.A.
      • 10.5.1 GamaMabs Pharma S.A. Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 3
      • 10.5.4 Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction
      • 10.5.5 GamaMabs Pharma S.A. Recent Development
    • 10.6 GlaxoSmithKline Plc
      • 10.6.1 GlaxoSmithKline Plc Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 3
      • 10.6.4 Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction
      • 10.6.5 GlaxoSmithKline Plc Recent Development
    • 10.7 Hanmi Pharmaceuticals, Co. Ltd.
      • 10.7.1 Hanmi Pharmaceuticals, Co. Ltd. Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 3
      • 10.7.4 Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction
      • 10.7.5 Hanmi Pharmaceuticals, Co. Ltd. Recent Development
    • 10.8 ImmunoGen, Inc.
      • 10.8.1 ImmunoGen, Inc. Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 3
      • 10.8.4 Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction
      • 10.8.5 ImmunoGen, Inc. Recent Development
    • 10.9 Kolltan Pharmaceuticals, Inc.
      • 10.9.1 Kolltan Pharmaceuticals, Inc. Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 3
      • 10.9.4 Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction
      • 10.9.5 Kolltan Pharmaceuticals, Inc. Recent Development
    • 10.10 Merrimack Pharmaceuticals, Inc.
      • 10.10.1 Merrimack Pharmaceuticals, Inc. Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Receptor Tyrosine Protein Kinase ERBB 3
      • 10.10.4 Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction
      • 10.10.5 Merrimack Pharmaceuticals, Inc. Recent Development
    • 10.11 Merus B.V.
    • 10.12 Novartis AG
    • 10.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
    • 10.14 Sihuan Pharmaceutical Holdings Group Ltd.
    • 10.15 Sorrento Therapeutics, Inc.
    • 10.16 Symphogen A/S
    • 10.17 Takis S.r.l.

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Receptor Tyrosine Protein Kinase ERBB 3 Sales Channels
      • 11.2.2 Receptor Tyrosine Protein Kinase ERBB 3 Distributors
    • 11.3 Receptor Tyrosine Protein Kinase ERBB 3 Customers

    12 Market Forecast

    • 12.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales and Revenue Forecast 2019-2025
    • 12.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Type
    • 12.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Application
    • 12.4 Receptor Tyrosine Protein Kinase ERBB 3 Forecast by Regions
      • 12.4.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Receptor Tyrosine Protein Kinase ERBB 3 is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Receptor Tyrosine Protein Kinase ERBB 3.

      This report studies the global market size of Receptor Tyrosine Protein Kinase ERBB 3, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Receptor Tyrosine Protein Kinase ERBB 3 sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      AstraZeneca Plc
      AVEO Pharmaceuticals, Inc.
      Etubics Corporation
      F. Hoffmann-La Roche Ltd.
      GamaMabs Pharma S.A.
      GlaxoSmithKline Plc
      Hanmi Pharmaceuticals, Co. Ltd.
      ImmunoGen, Inc.
      Kolltan Pharmaceuticals, Inc.
      Merrimack Pharmaceuticals, Inc.
      Merus B.V.
      Novartis AG
      Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
      Sihuan Pharmaceutical Holdings Group Ltd.
      Sorrento Therapeutics, Inc.
      Symphogen A/S
      Takis S.r.l.

      Market Segment by Product Type
      BA-0702
      CDX-3379
      Elgemtumab
      ETBX-031
      Others

      Market Segment by Application
      Non-Small Cell Carcinoma
      Solid Tumor
      Melanoma
      Colorectal Cancer
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Receptor Tyrosine Protein Kinase ERBB 3 status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Receptor Tyrosine Protein Kinase ERBB 3 manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Receptor Tyrosine Protein Kinase ERBB 3 are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now